The detection rates of mutations of KRAS, TP53, CDKN2A, and SMAD4.

Cite Download Share Embed

The detection rates of mutations of KRAS, TP53, CDKN2A, and SMAD4.

2020-01-30T18:40:08Z (GMT) by Tetsuya Ishizawa Naohiko Makino Akiko Matsuda Yasuharu Kakizaki Toshikazu Kobayashi Chisaki Ikeda Shinpei Sugahara Michihiko Tsunoda Yoshiyuki Ueno

The detection rates of mutations of KRAS, TP53, CDKN2A, and SMAD4.

Keyword(s)

KRAS mutation analysis retrospective study Pancreatic cancer 2A 2017. DNA sequences cancer gene panel testing SMAD CDKN endoscopic ultrasound-guided fine-needle aspiration polymerase chain reaction NGS ROSE specimens unresectable PC patients 5- year survival rate KRAS mutations TP Ion AmpliSeq Comprehensive Caner Panel

License

CC BY 4.0

Export

RefWorks

BibTeX

Endnote

DataCite

NLM

The detection rates of mutations of KRAS, TP53, CDKN2A, and SMAD4.

Categories

Keyword(s)

License

Export